Heart patients get a digital nudge: app aims to boost pill-taking

NCT ID NCT06951451

ENROLLING_BY_INVITATION Disease control Sponsor: Sultan Qaboos University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a smartphone app called MED-AD that sends reminders and tracks medication use for people with heart disease, high blood pressure, or high cholesterol. About 1,000 adults in Oman will be randomly assigned to use the app, receive daily text reminders, or get usual care. Researchers will measure how well participants take their medications over 12 months, and whether the app leads to better blood pressure, cholesterol, and fewer heart complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: smartphone application (MED-AD)
What this could lead to: If it works, this could provide a simple, low-cost way to help heart patients stick to their medications and improve their health.
What could go wrong: This is a behavioral study, not a drug trial. Success depends on patients actually using the app, and results may not apply to those without smartphones or reading skills.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia hypertensive disorder myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERLIPIDEMIA HYPERTENSION ISCHEMIC CARDIOVASCULAR DISEASE

Contacts and locations

Locations

Ministry of Health

Muscat, Oman

More trials for these conditions

Other studies related to the condition(s) this trial covers.